Sunshine Biopharma Inc [NASDAQ: SBFM] loss -6.06% or -0.1 points to close at $1.55 with a heavy trading volume of 292834 shares.
It opened the trading session at $1.65, the shares rose to $1.65 and dropped to $1.53, the range by which the price of stock traded the whole day. The daily chart for SBFM points out that the company has recorded -44.84% loss over the past six months.
If we look at the average trading volume of 389.83K shares, SBFM reached to a volume of 292834 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Sunshine Biopharma Inc [SBFM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SBFM shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SBFM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.18, with the Price to Cash per share for the same quarter was set at 1.78.
Trading performance analysis for SBFM stock
Sunshine Biopharma Inc [SBFM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.44. With this latest performance, SBFM shares dropped by 0.00% in over the last four-week period, additionally sinking by -44.84% over the last 6 months – not to mention a drop of -48.33% in the past year of trading.
Sunshine Biopharma Inc [SBFM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Sunshine Biopharma Inc [SBFM] shares currently have an operating margin of -15.75% and a Gross Margin at 29.81%. Sunshine Biopharma Inc’s Net Margin is presently recorded at -13.88%.
Return on Equity for this stock declined to -16.47%, with Return on Assets sitting at -16.47%.
An analysis of Institutional ownership at Sunshine Biopharma Inc [SBFM]
There are presently around $1.74%, or 1.80% of SBFM stock, in the hands of institutional investors.
